A genetically engineered sheep model of HPP was created to better elucidate the mechanisms of HPP pathophysiology, and the model accurately replicated low levels of serum ALPL, low bone mineral density, and impaired gait [19]. The gene discussed is ALPL; the disease is hypophosphatasia.